Advances in Mitochondria-Targeted Drug Delivery

This publication has 26 references indexed in Scilit:

• The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy
  Science Translational Medicine, 2021
• Therapeutic Approaches to Treat Mitochondrial Diseases: “One-Size-Fits-All” and “Precision Medicine” Strategies
  Pharmaceutics, 2020
• Targeting Multiple Mitochondrial Processes by a Metabolic Modulator Prevents Sarcopenia and Cognitive Decline in SAMP8 Mice
  Frontiers in Pharmacology, 2020
• Classification and molecular pathogenesis of NBIA syndromes
  European Journal of Paediatric Neurology, 2018
• Emerging concepts in the therapy of mitochondrial disease
  Biochimica et Biophysica Acta (BBA) - Bioenergetics, 2015
• Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model
  Brain, 2013
• Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model
  Human Molecular Genetics, 2012
• C19orf12 and FA2H Mutations Are Rare in Italian Patients With Neurodegeneration With Brain Iron Accumulation
  Seminars in Pediatric Neurology, 2012
• Absence of an Orphan Mitochondrial Protein, C19orf12, Causes a Distinct Clinical Subtype of Neurodegeneration with Brain Iron Accumulation
  The American Journal of Human Genetics, 2011
• Pantothenate kinase-associated neurodegeneration (formerly Hallervorden–Spatz Syndrome)
  Journal of the Neurological Sciences, 2003